Taylor R - Search Results

1

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Ofei F, et al. Among authors: taylor r. Diabetes. 1996 Jul;45(7):881-5. doi: 10.2337/diab.45.7.881. Diabetes. 1996. PMID: 8666137 Clinical Trial.

2

The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes.

Sum CF, Webster JM, Johnson AB, Catalano C, Cooper BG, Taylor R. Sum CF, et al. Among authors: taylor r. Diabet Med. 1992 Jan-Feb;9(1):61-5. doi: 10.1111/j.1464-5491.1992.tb01716.x. Diabet Med. 1992. PMID: 1551312 Clinical Trial.

3

Five year audit of peripartum blood glucose control in type 1 diabetic patients.

Njenga E, Lind T, Taylor R. Njenga E, et al. Among authors: taylor r. Diabet Med. 1992 Jul;9(6):567-70. doi: 10.1111/j.1464-5491.1992.tb01840.x. Diabet Med. 1992. PMID: 1643807

4

Effect of bezafibrate on metabolic profiles in non-insulin-dependent diabetes mellitus.

Alberti KG, Jones IR, Laker MF, Swai AB, Taylor R. Alberti KG, et al. Among authors: taylor r. J Cardiovasc Pharmacol. 1990;16 Suppl 9:S21-4; discussion S24-5. J Cardiovasc Pharmacol. 1990. PMID: 1710741 Clinical Trial.

5

The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients.

Johnson AB, Argyraki M, Thow JC, Jones IR, Broughton D, Miller M, Taylor R. Johnson AB, et al. Among authors: taylor r. Diabet Med. 1991 Apr;8(3):243-53. doi: 10.1111/j.1464-5491.1991.tb01580.x. Diabet Med. 1991. PMID: 1828740 Clinical Trial.

6

Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity.

Johnson AB, Argyraki M, Thow JC, Jones IR, Broughton D, Miller M, Taylor R. Johnson AB, et al. Among authors: taylor r. Metabolism. 1991 Mar;40(3):252-60. doi: 10.1016/0026-0495(91)90106-7. Metabolism. 1991. PMID: 1900343

7

Peripheral and hepatic insulin sensitivity in healthy elderly human subjects.

Broughton DL, James OW, Alberti KG, Taylor R. Broughton DL, et al. Among authors: taylor r. Eur J Clin Invest. 1991 Feb;21(1):13-21. doi: 10.1111/j.1365-2362.1991.tb01352.x. Eur J Clin Invest. 1991. PMID: 1907550

8

Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients.

Johnson AB, Argyraki M, Thow JC, Broughton D, Jones IR, Taylor R. Johnson AB, et al. Among authors: taylor r. Diabet Med. 1990 Jun;7(5):420-8. doi: 10.1111/j.1464-5491.1990.tb01417.x. Diabet Med. 1990. PMID: 2142039

9

Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin.

Thow JC, Johnson AB, Marsden S, Taylor R, Home PD. Thow JC, et al. Among authors: taylor r. Diabet Med. 1990 Nov;7(9):795-9. doi: 10.1111/j.1464-5491.1990.tb01494.x. Diabet Med. 1990. PMID: 2148131

10

Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM.

Jones IR, Swai A, Taylor R, Miller M, Laker MF, Alberti KG. Jones IR, et al. Among authors: taylor r. Diabetes Care. 1990 Aug;13(8):855-63. doi: 10.2337/diacare.13.8.855. Diabetes Care. 1990. PMID: 2209320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,144 results

Search Page

Filters